Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Natco Pharma Ltd
- Retatrutide is studied as a multi-receptor peptide in controlled research environments where investigators are evaluating the interaction between GLP-1 receptor signaling, GIP receptor activity, glucagon receptor pathways, metabolic adaptation, insulinotropic pathway behavior, appetite-associated signaling models, and energy expenditure biology
Be alert for signs of pancreatitis, gallbladder problems, kidney problems (often related to dehydration), severe allergic reactions, and low blood sugar (hypoglycemia) if you take insulin or sulfonylureas
Doctors may prescribe a GLP-1 agonist to people who: Have Type 2 diabetes, especially if other medications such as metformin which are usually used first arent enough
US$ 25.16
US$ 27.37
US$ 27.97
US$ 23.35
US$ 20.09
US$ 29.40
